Corrigendum to "IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression" [Immunol. Lett. 216 (2019) 12-20
| Errataetall: |
ErratumFor: Immunol Lett. 2019 Dec;216:12-20. - PMID 31545959 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:232 |
|---|---|
| Enthalten in: |
Immunology letters - 232(2021) vom: 28. Apr., Seite 67 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gharibi, Tohid [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 19.03.2021 published: Print-Electronic ErratumFor: Immunol Lett. 2019 Dec;216:12-20. - PMID 31545959 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.imlet.2020.12.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320242919 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320242919 | ||
| 003 | DE-627 | ||
| 005 | 20231225173148.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.imlet.2020.12.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1067.xml |
| 035 | |a (DE-627)NLM320242919 | ||
| 035 | |a (NLM)33461760 | ||
| 035 | |a (PII)S0165-2478(20)30441-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gharibi, Tohid |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression" [Immunol. Lett. 216 (2019) 12-20 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 19.03.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Immunol Lett. 2019 Dec;216:12-20. - PMID 31545959 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Hosseini, Arezoo |e verfasserin |4 aut | |
| 700 | 1 | |a Marofi, Faroogh |e verfasserin |4 aut | |
| 700 | 1 | |a Oraei, Mona |e verfasserin |4 aut | |
| 700 | 1 | |a Jahandideh, Saeed |e verfasserin |4 aut | |
| 700 | 1 | |a Abdollahpour-Alitappeh, Meghdad |e verfasserin |4 aut | |
| 700 | 1 | |a Hashemi, Vida |e verfasserin |4 aut | |
| 700 | 1 | |a Motallebnezhad, Morteza |e verfasserin |4 aut | |
| 700 | 1 | |a Babaloo, Zohreh |e verfasserin |4 aut | |
| 700 | 1 | |a Baradaran, Behzad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunology letters |d 1983 |g 232(2021) vom: 28. Apr., Seite 67 |w (DE-627)NLM012603953 |x 1879-0542 |7 nnns |
| 773 | 1 | 8 | |g volume:232 |g year:2021 |g day:28 |g month:04 |g pages:67 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.imlet.2020.12.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 232 |j 2021 |b 28 |c 04 |h 67 | ||